Modulation of the Mu and Kappa Opioid Axis for the Treatment of Chronic Pruritus

Main Article Content

Sarina Elmariah
Massachusetts General Hospital, Boston, MA, USA

Sarah Chisolm
Emory University Department of Dermatology, Atlanta, GA

Thomas Sciascia
Trevi Therapeutics, New Haven, CT

Shawn Kwatra
Johns Hopkins University School of Medicine, Baltimore, MD

Keywords

Chronic Pruritus, Mu Receptor, Kappa Receptor, Modulation

Abstract

Abstract not available.

References

1. Tsianakas A, et al. Curr Probl Dermatol. 2016;50:94-101.

2. Ramakrishnan K, et al. Int J Nephrol Renovasc Dis. 2013;7:1-12.

3. Fowler E, Yosipovitch G. Acta Derm Venereol. 2020;100(2):adv00027.

4. Rehman IU, et al. Medicina (Kaunas). 2019;55(10).

5. Satti MZ, et al. Cureus. 2019;11(7):e5178.

6. Todberg T, et al. Acta Derm Venereol. 2020;100(8):adv00119.

7. Janmohamed SR, et al. Arch Dermatol Res. 2020.

8. Tubog TD, et al. J Perianesth Nurs. 2019;34(3):491-501.e8.

9. Kardon AP, et al. Neuron. 2014;82(3):573-86.

10. Valentino RJ, Volkow ND. Neuropsychopharmacology. 2018;43(13):2514-20.

11. Noble F, et al. Br J Pharmacol. 2015;172(16):3964-79.

12. Beck TC, et al. Pharmaceuticals (Basel). 2019;12(2).

13. Wang S. Cell Transplant. 2019;28(3):233-8.

14. Phan NQ, et al. Acta Derm Venereol. 2012;92(5):555-60.

15. Bigliardi-Qi M, et al. Dermatology. 2005;210(2):91-9.

16. Yosipovitch G, et al. J Allergy Clin Immunol. 2018;142(5):1375-90.

17. Kupczyk P, et al. Acta Derm Venereol. 2017;97(5):564-70.

18. Wieczorek A, et al. J Eur Acad Dermatol Venereol. 2020;34(10):2368-72.

19. Fowler E, Yosipovitch G. Ann Allergy Asthma Immunol. 2019;123(2):158-65.

20. Lee J, et al. Ann Dermatol. 2016;28(2):159-63.

21. Kumagai H, et al. Nephrol Dial Transplant. 2010;25(4):1251-7.

22. Fishbane S, et al. Kidney Int Rep. 2020;5(5):600-10.

23. Fishbane S, et al. N Engl J Med. 2020;382(3):222-32.

24. Khanna R, et al. J Am Acad Dermatol. 2020;83(5):1529-33.

25. Mathur VS, et al. Am J Nephrol. 2017;46(6):450-8.

26. Data on file, Trevi Therapeutics, New Haven, CT, USA.

Article Sidebar

Poster PDF
Published
Jan 1, 2021
DOI https://doi.org/10.25251/skin.5.supp.30

Article Details

How to Cite
Elmariah, S., Chisolm, S., Sciascia, T., & Kwatra, S. (2021). Modulation of the Mu and Kappa Opioid Axis for the Treatment of Chronic Pruritus. SKIN The Journal of Cutaneous Medicine, 5(1), s30. https://doi.org/10.25251/skin.5.supp.30
Issue
Vol. 5 No. 1 (2021): January Issue & Poster Presentations (WC21 Dermatology Conference®)
Section
Pruritus & Prurigo Nodularis
Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All authors retain copyright in their articles. All articles published open access allowing for immediate free access to the work and permitting any user to read, download, copy, distribute, print, search, or link to the full texts of articles, crawl them for indexing, pass them as data to software or use them for any other lawful purpose. Permitted reuse is defined by  the following user license:
 

Creative Commons Attribution (CC BY): lets others distribute and copy the article, to create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), to include in a collective work (such as an anthology), to text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation. 

Authors retain copyright in their work and license the publisher to publish the content. The publisher is the National Society for Cutaneous Medicine, with production and publishing support provided by OJS, Open Journal Systems,see https://pkp.sfu.ca/ojs/.

Prior to January 2022, authors transferred copyright to the National Society for Cutaneous Medicine. However, all articles are freely available to anyone in the world. There are no subscription fees, page charges, or article processing charges.